Artthur Pappas

CEO & Managing General Partner · Pappas Capital

Art Pappas, CEO of Pappas Capital, invests primarily in life sciences—including biotechnology, biopharmaceuticals, drug delivery, and medical devices—targeting companies from seed stage through later-stage mezzanine, with a focus on Phase 1 or Phase 2 development [3][10]. The firm has invested in over 100 portfolio companies, with notable exits including 14 IPOs (e.g., Reneo Pharmaceuticals, BioA…

Stages: Early Stage Venture, Late Stage Venture
Focus: Biotechnology, Delivery, Medical Device, Pharmaceutical, Biotechnology, Pharmaceutical, Medical, Therapeutics, Health Care, Life Science, Chemical Engineering, Medical Device, Genetics, Agriculture, Early Stage Venture, Late Stage Venture
Location: Durham, NC

Website

Browse all investors · Browse founders